Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TAK and other ETFs, options, and stocks.

About TAK

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. 

CEO
Christophe Weber
CEOChristophe Weber
Employees
47,455
Employees47,455
Headquarters
Osaka, Osaka
HeadquartersOsaka, Osaka
Founded
1781
Founded1781
Employees
47,455
Employees47,455

TAK Key Statistics

Market cap
60.61B
Market cap60.61B
Price-Earnings ratio
74.82
Price-Earnings ratio74.82
Dividend yield
3.22%
Dividend yield3.22%
Average volume
2.68M
Average volume2.68M
High today
$18.75
High today$18.75
Low today
$18.56
Low today$18.56
Open price
$18.62
Open price$18.62
Volume
2.25M
Volume2.25M
52 Week high
$18.79
52 Week high$18.79
52 Week low
$12.99
52 Week low$12.99

TAK News

TipRanks 5h
Takeda announces data from Phase 3 KEPLER trial of ENTYVIO

Takeda (TAK) announced data from the pivotal Phase 3 KEPLER trial, which demonstrated that ENTYVIO can offer the possibility of clinical remission for patients...

TipRanks 1d
Takeda’s New Stroke Trial Adds Long-Term Optionality to TAK’s Pipeline

Takeda Pharmaceutical Company (TAK) announced an update on their ongoing clinical study. Takeda (TAK) is launching a Phase 2 trial titled “A Phase 2, Randomize...

TipRanks 1d
Takeda’s HyQvia Study Tracks Real-World Use in Multiple Myeloma, Offering Gradual Upside for TAK Investors

Takeda Pharmaceutical Company (TAK) announced an update on their ongoing clinical study. Takeda is running a prospective, observational study called “A Prospec...

Analyst ratings

53%

of 15 ratings
Buy
53.3%
Hold
40%
Sell
6.7%

More TAK News

TipRanks 1d
Takeda Targets Better Hereditary Angioedema Diagnosis With New AHAE Study

Takeda Pharmaceutical Company (TAK) announced an update on their ongoing clinical study. Takeda (TAK) is backing a new diagnostic study for hereditary angioede...

TipRanks 6d
Takeda Advances Phase 3 Teen Depression Trial, Underscoring Its Neuroscience Strategy

Takeda Pharmaceutical Company (TAK) announced an update on their ongoing clinical study. Takeda (TAK) is running a Phase 3 study called “A Randomized, Double-b...

TipRanks 6d
Takeda Pushes Pediatric Psoriasis Drug TAK-279 Forward With New Phase 3 Trial Update

Takeda Pharmaceutical Company (TAK) announced an update on their ongoing clinical study. Takeda is running a phase 3 trial to test its drug zasocitinib in chil...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.